Evidence map›Paper›PMID 31354188›Full record

ArticleSynlett : accounts and rapid communications in synthetic organic chemistry2018

Artificial Macrocycles.

Eman M M Abdelraheem, Shabnam Shaabani, Alexander Dömling

Abstract read
In one paragraph

Article in Synlett : accounts and rapid communications in synthetic organic chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Multicomponent Macrocyclic IL-17a Modifier.ACS medicinal chemistry letters · 2022
    Article
  6. Benchmark of Generic Shapes for Macrocycles.Journal of chemical information and modeling · 2020
    Article
  7. Article
  8. Review
  9. Article
  10. Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists.Beilstein journal of organic chemistry · 2019
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eman M M AbdelraheemUniversity of Groningen, Department of Drug Design, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands, a.s.s.domling@rug.nl.ORCID 0000-0002-9008-2729
Shabnam ShaabaniUniversity of Groningen, Department of Drug Design, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands, a.s.s.domling@rug.nl.ORCID 0000-0001-5546-7140
Alexander DömlingUniversity of Groningen, Department of Drug Design, A. Deusinglaan 1, 9713 AV Groningen, The Netherlands, a.s.s.domling@rug.nl.ORCID 0000-0002-9923-8873

Funding

Real-time discovery of inhibitors among billion compounds for preview and downloadR01GM097082 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CAMACHO, CARLOS J. · 2011 to 2020
$2.5M
NIGMS NIH HHS R01 GM097082
6 · The paper itself

Abstract

Artificial macrocycles recently became popular as a novel research field in drug discovery. As opposed to their natural twins, artificial macrocycles promise to have better control on synthesizability and control over their physicochemical properties resulting in druglike properties. Very few synthetic methods allow for the convergent, fast but diverse access to large macrocycles chemical space. One synthetic technology to access artificial macrocycles with potential biological activity, multicomponent reactions, is reviewed here, with a focus on our own work. We believe that synthetic chemists have to acquaint themselves more with structure and activity to leverage the design aspect of their daily work.

Indexed as

bioactivitybioavailabilityconvergencedruglike propertiesmacrocyclemulticomponent reactionproperty spacesynthetic pathway

Identifiers

PMID31354188
PMCPMC6660156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.